DERM - Dermira, Inc.
| Previous Close | 18.74 |
| Open | 18.75 |
| Bid | 0.00 x 41800 |
| Ask | 0.00 x 1100 |
| Day's Range | 18.73 - 18.75 |
| 52 Week Range | 5.25 - 19.48 |
| Volume | 637,154 |
| Avg. Volume | 2,370,913 |
| Market Cap | 1.025B |
| Beta (5Y Monthly) | 1.65 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.37 |
| Earnings Date | Nov 04, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.50 |
- GlobeNewswire
(DERM) Alert: Johnson Fistel Continues Investigation of Proposed Sale of Dermira, Inc. for $19.30
On January 10, 2020, Dermira announced that it had signed a definitive merger agreement with Lilly. The investigation concerns whether the Dermira board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Dermira shares of common stock.
- ACCESSWIRE
INVESTOR ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - LOGM, DERM, HXL
NEW YORK, NY / ACCESSWIRE / February 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: LogMeIn, Inc. (NASDAQ:LOGM) The investigation concerns ...
- GlobeNewswire
CSFL, DLPH, DERM, and HXL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
WILMINGTON, Del., Feb. 04, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: CenterState Bank Corporation (NASDAQ GS: CSFL) regarding possible breaches of.
- ACCESSWIRE
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - HXL, DERM, HABT
NEW YORK, NY / ACCESSWIRE / January 30, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Hexcel Corporation (NYSE:HXL) The investigation concerns ...
- Zacks
Lilly (LLY) Q4 Earnings and Sales Top Estimates, Stock Up
Eli Lilly's (LLY) Q4 earnings and sales beat estimates. Shares rise in pre-market trading.
- GlobeNewswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds CBB, HABT, DERM, and MFSF Shareholders About Its Ongoing Investigations
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Cincinnati Bell Inc. (CBB) in connection with the proposed acquisition of the Company by Brookfield Infrastructure Partners L.P. Under the terms of the acquisition agreement, CBB shareholders will receive $10.50 in cash for each CBB share that they own. Weiss Law LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of The Habit Restaurants, Inc. (HABT) in connection with the proposed acquisition of the Company by Yum!
- GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – HABT, DERM, HXL, PRMW
NEW YORK, Jan. 29, 2020 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: The Habit Restaurants, Inc. (NASDAQ: HABT)The.
- GlobeNewswire
PRMW, DERM, HABT, and HXL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
WILMINGTON, Del., Jan. 28, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: Primo Water Corporation (NASDAQ GS: PRMW) regarding possible breaches of.
- Zacks
Lilly (LLY) to Report Q4 Earnings: What's in the Cards?
Eli Lilly and Company's (LLY) new drugs like Trulicity, Taltz and Jardiance are likely to have performed well. Let's see if these along with older products lead to an earnings beat for the company.
- GlobeNewswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds HABT, DERM, and MFSF Shareholders About Its Ongoing Investigations
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of The Habit Restaurants, Inc. (HABT) in connection with the proposed acquisition of the Company by Yum! Brands, Inc. Under the terms of the acquisition agreement, HABT shareholders will receive $14.00 in cash for each HABT share they own.
- ACCESSWIRE
MERGER ALERT - INST, DERM, and PRMW: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
NEW YORK, NY / ACCESSWIRE / January 20, 2020 / The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders ...
- GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – CBB, HABT, DERM, IBKC
NEW YORK, Jan. 20, 2020 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cincinnati Bell Inc. (NYSE: CBB) The.
- GlobeNewswire
DERM, CRCM, LOGM, and WAAS SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
WILMINGTON, Del., Jan. 15, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: Dermira, Inc. (NASDAQ GS: DERM) regarding possible breaches of fiduciary.
- Thomson Reuters StreetEvents
Edited Transcript of DERM earnings conference call or presentation 5-Nov-19 9:30pm GMT
Q3 2019 Dermira Inc Earnings Call
- PR Newswire
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Dermira, Primo Water, Hexcel, and Pope Resources on behalf of Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Dermira, Inc. (NASDAQ: DERM), Primo Water Corporation (NASDAQ: PRMW), Hexcel Corporation (NYSE: HXL), and Pope Resources, A Delaware Partnership (NASDAQ: POPE). Additional information about each potential action can be found at the link provided.
- PR Newswire
Moore Kuehn, PLLC Encourages PRMW, DERM, CBB, and HABT Investors to Contact Firm
Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Shareholders should contact the firm immediately as there may be only a small window of time to enforce your rights:
- Barrons.com
Big Merger Deals Are Missing at Health Conference. Here’s Why.
What a difference a year makes. The start of the annual J.P. Morgan Healthcare investor conference in 2019 brought a double-header of giant deals. In 2020, there was almost nothing.
- ACCESSWIRE
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Dermira, Inc. - (Nasdaq:DERM)
BALA CYNWYD, PA / ACCESSWIRE / January 13, 2020 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Dermira, Inc. ("Dermira" ...
- ACCESSWIRE
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Dermira, Inc. to Eli Lilly and Company is Fair to Shareholders
NEW YORK, NY / ACCESSWIRE / January 13, 2020 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Dermira, Inc. ("Dermira" or the "Company") ...
- Zacks
Lilly to Buy Dermira for $1.1B, Add Phase III Eczema Candidate
Lilly (LLY) offers to buy Dermira for $1.1 billion to add the latter's late-stage candidate for atopic dermatitis/eczema, lebrikizumab.
- ACCESSWIRE
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - CBB, HABT, DERM
NEW YORK, NY / ACCESSWIRE / January 11, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cincinnati Bell Inc. (NYSE:CBB) The investigation concerns ...
- American City Business Journals
Biotechs punch up talking points leading into big Union Square conference
Life sciences companies like to release a flurry of news in the days ahead of the giant J.P. Morgan Healthcare Conference in San Francisco to create fresh nuggets for potential investors and partners to gnaw on. Yet too much noise sometimes can hurt their message.
- Barrons.com
Eli Lilly Made a Deal for Dermira. The Biotech’s Stock Price Shows Investors Expect More.
A Lilly executive says the $1.1 billion all-cash deal is fair, but the stock price indicates investors anticipate a higher valuation.
